Real life results of direct-acting oral anticoagulants recommended-dose in obese vs normal-weight patients with venous thromboembolism
JA Rueda-Camino, R Barba, S Otálora… - Thrombosis …, 2024 - Elsevier
Background There is scarce evidence on the effectiveness and safety of recommended-
dose direct acting oral anticoagulants (DOACs) in obese patients with venous …
dose direct acting oral anticoagulants (DOACs) in obese patients with venous …
Efficacy and Safety of Direct Oral Anticoagulants versus Warfarin in Obese Patients (BMI ≥ 30 kg/m2) with Atrial Fibrillation or Venous Thromboembolism: An …
P Karakasis, N Ktenopoulos, K Pamporis… - Journal of Clinical …, 2024 - mdpi.com
Background: Real-world data show limited utilization of direct oral anticoagulants (DOACs)
in obese patients (body mass index [BMI]≥ 30 kg/m2) due to concerns regarding their …
in obese patients (body mass index [BMI]≥ 30 kg/m2) due to concerns regarding their …
Machine learning approach for prediction of outcomes in anticoagulated patients with atrial fibrillation
Background The accuracy of available prediction tools for clinical outcomes in patients with
atrial fibrillation (AF) remains modest. Machine Learning (ML) has been used to predict …
atrial fibrillation (AF) remains modest. Machine Learning (ML) has been used to predict …